135 related articles for article (PubMed ID: 3452790)
1. [Remote afterloading high dose rate intracavitary therapy of carcinoma of the uterine cervix. II. Risk factor of rectal complication].
Teshima T; Chatani M; Inoue T
Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Dec; 47(12):1566-71. PubMed ID: 3452790
[No Abstract] [Full Text] [Related]
2. [Remote afterloading high dose rate intracavitary therapy in carcinoma of the uterine cervix].
Monzen Y; Ajimu A; Yamada K; Yoshida S; Hayashi N; Morikawa M; Ashizawa K; Hayashi K; Honbo Z
Rinsho Hoshasen; 1988 Nov; 33(12):1565-8. PubMed ID: 3221475
[No Abstract] [Full Text] [Related]
3. Rectal complication after remote afterloading intracavitary therapy for carcinoma of the uterine cervix.
Teshima T; Chatani M; Hata K; Inoue T; Inoue T; Suzuki T
Strahlentherapie; 1985 Jun; 161(6):343-7. PubMed ID: 4012814
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of rectal and bladder complications after RALS therapy for carcinoma of the uterine cervix].
Teshima T; Chatani M; Hata K; Inoue T; Suzuki T
Gan No Rinsho; 1984 Nov; 30(14):1793-800. PubMed ID: 6513032
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
[TBL] [Abstract][Full Text] [Related]
6. Geometrical sparing factors for the rectum and bladder in the prediction of grade 2 and higher complications after high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1335-43. PubMed ID: 19386443
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
[TBL] [Abstract][Full Text] [Related]
8. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
[TBL] [Abstract][Full Text] [Related]
9. Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer.
Suzuki O; Yoshioka Y; Isohashi F; Morimoto M; Kotsuma T; Kawaguchi Y; Konishi K; Nakamura S; Shiomi H; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1329-34. PubMed ID: 18439763
[TBL] [Abstract][Full Text] [Related]
10. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
[TBL] [Abstract][Full Text] [Related]
12. [Remote afterloading high-dose rate intracavitary therapy of carcinoma of the uterine cervix. I. Survival, prognostic factors, cause of death and patterns of failure and complication].
Teshima T; Chatani M; Inoue T
Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jun; 47(6):821-8. PubMed ID: 3684523
[No Abstract] [Full Text] [Related]
13. A prospective randomized study concerning to the point A dose in high-dose rate intracavitary radiation therapy for carcinoma of the uterine cervix.
Chatani M; Teshima T; Inoue T
Strahlenther Onkol; 1991 Dec; 167(12):701-7. PubMed ID: 1763406
[TBL] [Abstract][Full Text] [Related]
14. A modified dose monitoring system in remote afterloading therapy of carcinoma of the uterine cervix using semi-conductor dosimeter.
Inoue T; Inoue T; Harada K; Hata K; Ozawa R; Kawanabe K
Strahlentherapie; 1981 Jun; 157(6):400-4. PubMed ID: 7256809
[TBL] [Abstract][Full Text] [Related]
15. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
16. [Rectal complication following RALS therapy for cervical cancer: analysis of variance].
Inoue T; Inoue T; Suzuki T
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Jul; 43(7):922-7. PubMed ID: 6415613
[No Abstract] [Full Text] [Related]
17. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
18. [Low-dose rate intracavitary afterloading radiotherapy for cancer of uterine cervix].
Zhang X; Wang Y; Wang H
Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):294-6. PubMed ID: 12515631
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
[TBL] [Abstract][Full Text] [Related]
20. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy.
Georg P; Lang S; Dimopoulos JC; Dörr W; Sturdza AE; Berger D; Georg D; Kirisits C; Pötter R
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):356-62. PubMed ID: 20385450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
